Live feed
·
INSIDERFiling
CRISPR Therapeutics AG logo

Chief Executive Officer Kulkarni Samarth converted options into 13,250 shares and sold $366,325 worth of shares (6,967 units at $52.58), increasing direct ownership by 3% to 226,106 units (SEC Form 4)